1. Introduction {#s0005}
===============

Histoplasmosis is a fungal disease caused by the family of genus *Histoplasma*, which exists prevalently in the Americas, and rarely reported in China. *Histoplasma* can survive at temperature 22--29 °C in moist soils, with high acidity and nitrogen content. They can often be isolated from soils containing decaying bat and bird feces, but rarely isolated from fresh feces. Human activities cause the formation of fungal aerosols from surface soil, which can cause infection once inhaled \[[@bb0005], [@bb0010], [@bb0015]\].

In March 2019, 14 employees from Chongqing Bosai Mining Company, China, working in a manganese mining of Guyana, suffered from unexplained fever. Ten of them were treated in the Georgetown Public Hospital (GPHC) of Guyana, one in the mine hospital, and one was isolated in their hotel. Two patients died. Ten patients and the brain and lung tissues of these deceased individuals were transported to China by a Chinese Red Cross rescue aircraft on April 5th. The autopsy was performed by local doctors in the GPHC. After preliminary examination of the 10 patients by GPHC, potential infectious pathogens like *Leptospira*, HIV, Influenza H1N1, Zika virus, Chikungunya virus, Dengue virus, and Influenza A and B viruses were excluded.

We report here the identification of *Histoplasma* as the pathogen of this unexplained disease cluster in Matthews Ridge Guyana. Pathological examination, high-throughput sequencing, and real-time PCR were applied, and the strategy and workflow of the identification were summarized in [Figure 1](#f0005){ref-type="fig"} .Figure 1Strategy and workflow of pathogen identification.Fig. 1

2. Materials and methods {#s0010}
========================

2.1. Sample preparation and nucleic acid extraction {#s0015}
---------------------------------------------------

Basic information of the 12 patients (two deaths, one severe case, and nine mild cases) and sample types were listed in [Table 1](#t0005){ref-type="table"} . All patients were male at ages from 30 to 56, and in general good health condition before infected. The 10 patients hospitalized in the GPHC showed all patients were male and their median age was 46 years. Tissue samples from the two deceased subjects (No. 1 and No. 2) were cut into 5 mm^3^ pieces, then put into freeze-storage tubes containing 500 μL sterile phosphate-buffered saline and repeatedly homogenized using an electric tissue grinder for 30 s with 1 min intervals until the tissues were completely dispersed. Nucleic acids were then extracted from 200 μL of homogenized samples using a QIAamp MinElute Virus Spin Kit (Qiagen, Germany) following the manufacturer\'s instructions. All operations were performed in a BSL-3 laboratory.Table 1Basic demographic data of the patients involved in this epidemic.Table 1Patient No.AgeSample types146Lung tissue (autopsy)244Brain tissue (autopsy), serum342Plasma, bronchoscopy lavages, cerebrospinal fluid (severe, but survived)450Blood, nasopharyngeal swabs532Blood, nasopharyngeal swabs643Blood, nasopharyngeal swabs750Blood, nasopharyngeal swabs848Blood, nasopharyngeal swabs956Blood, nasopharyngeal swabs1030Blood, nasopharyngeal swabs1140Blood, nasopharyngeal swabs1247Blood, nasopharyngeal swabs

2.2. Pathological examination {#s0020}
-----------------------------

### 2.2.1. Histochemical staining {#s0025}

Tissue specimens obtained from the autopsy of multiple tissue locations were embedded in paraffin blocks, then stained with hematoxylin-eosin (HE) and periodic acid-Schiff (PAS). For liquid specimens, including bronchoalveolar lavage fluid, anticoagulated blood, plasma, and cerebrospinal fluid (CSF) were made into smears; Giemsa staining and PAS staining were used respectively for histochemical examination.

### 2.2.2. Nanopore sequencing {#s0030}

For nanopore sequencing, the Ligation Sequencing Kit 1D R9 (ONT, SQK-LSK108) was applied to prepare libraries. End-repair was performed using NEBNext Ultra II End-repair/dA-tailing Module (New England BioLabs). Ligation was performed using a NEBNext Quick Ligation Module (New England BioLabs). The library was then ready for sequencing on the MinION system. During library incubation, the MinION was assembled with the Flow Cell Mk 1 Spot-ON Pk.1 (ONT, FLO-MIN 106 R9) and was connected to a computer (Windows 10; two Xeon E5-2640 v4; 128 GBDDR4 of 2133 MHz; SSD1TB) *via* a USB 3.0 hub. The sequencing library was loaded into the flow cell using Library Loading Bead Kit R9 (ONT, EXP-LLB001) according to the manufacturer\'s instructions. A 48-h sequencing plus base-caller protocol was selected in MinKNOW software and the sequencing process was stopped according to experimental needs \[[@bb0020]\]. Data were obtained by MinKNOW software and analyzed using the Albacore pipeline.

### 2.2.3. Next-generation sequencing (NGS) {#s0035}

NGS was independently performed by the National Institute for Viral Disease Control and Prevention (IVDC); Beijing University of Chemical Technology (BUCT); and Beijing Institute of Genome Research-Chinese Academy of Sciences and BGI Group (BGI). NGS is used by IVDC in response to emergency situations \[[@bb0025], [@bb0030], [@bb0035]\]. In the present case, the NGS processes in IVDC were conducted on an Ion Torrent PGM with Hi-Q View Kit and 318 v2 chip, and on an Illumina MiniSeq system with Nextera XT Kit and MiniSeq High-output sequencing Kit, and on an MGISEQ 2000. The data were downloaded and analyzed with our in-house Virus Identification Pipeline (VIP). Reads from NGS platforms were analyzed by an advanced version of the VIP \[[@bb0040]\]. Based on the results of third-generation sequencing (TGS, specifically nanopore sequencing in this study), we used the genome sequence of *H. capsulatum* as a reference for VIP. Generally, raw NGS reads were first preprocessed by the removal of adapter, low-quality, and low-complexity sequences. Next, clean reads were classified at the genus level. This step performed both nucleotide and amino acid homology alignments against a custom database which included the host genome (hg38) and a comprehensive collection of bacteria, fungi, parasite and virus sequences (derived from NT collection, May 2018) by Centrifuge \[[@bb0045]\] and Kaiju \[[@bb0050]\]. In addition, all classified reads under a genus were subject to *de novo* assembly and phylogenetic analysis \[[@bb0055]\]. The selected high-confidence reads and contigs were rechecked on web BLAST.

### 2.2.4. Real-time PCR {#s0040}

Real-time PCR was performed on all samples from the 12 patients to screen for Influenza A virus (in-house developed), Coronavirus (in-house developed), Black creek canal virus (in-house developed), Andes virus (in-house developed), Guanarito virus (in-house developed), Sabia virus (in-house developed), Nipah virus (in-house developed), Flavivirus (in-house developed), *Leptospira* \[[@bb0060],[@bb0065]\], and *Histoplasma* \[[@bb0070],[@bb0075]\], according to the cited publications or in-house protocols.

3. Results {#s0045}
==========

3.1. Clinical symptoms and epidemiologic investigation {#s0050}
------------------------------------------------------

Most patients started with fever, headache, myalgia, loss of appetite, and hemorrhagic eruption on the skin. Two patients had intestinal symptoms. No human-to-human transmission was identified as the interpreter and patient roommates remained healthy. Six patients were admitted to the hospital on March 30th, and four on April 1st, 2019. The median time from onset to admission was 4 days (range 1--8 days).

3.2. Pathological analysis {#s0055}
--------------------------

Monocytes and neutrophils were examined in the plasma sample from patient No. 2 (deceased), and no abnormalities were observed. Bacteria were not observed in the plasma sample from patient No. 2, or in the CSF sample from patient No. 3 (severe case but survived). In the Giemsa-stained bronchoalveolar lavage fluid smear from patient No. 3, a large number of bacteria and scattered neutrophils were visible ([Figure 2](#f0015){ref-type="fig"} ). PAS staining of the paraffin sections of the lung tissue sample from deceased patient No. 1 showed spore-like structures ([Figure 3](#f0020){ref-type="fig"} ).Figure 2Giemsa stain of bronchoalveolar lavage fluid from patient No. 3 (severe but survived).Fig. 2Figure 3Periodic acid-Schiff staining of the lung tissue from patient No. 1 (deceased). The arrow indicates a spore-like structure.Fig. 3

3.3. High-throughput sequencing for samples from the two deceased cases and one severe case {#s0060}
-------------------------------------------------------------------------------------------

After nucleic acid extraction was completed, NGS and TGS were simultaneously implemented by IVDC. Brain tissue and serum from patient No. 2, and lung tissue from patient No. 1 were detected sequentially using the MinION system. The rate of data generation was monitored, and sequencing was stopped when the rate of data generation became very slow or the number of active nanopores was significantly lower. The sequencing times for the serum, brain tissue and lung tissue were approximately 10, 5, and 13 h, respectively, resulting in 252,000 reads, 96,261 reads, and 1,553,164 reads, respectively. No significant evidence was found in data from the brain tissue or serum sample obtained by MinION, but the reads of *Histoplasma* were identified in the lung tissue sample. A read of 280 bp was generated during the sequencing and matched with the NCBI (nt/nr) database sequence of *Histoplasma* NAm1 predicted protein partial mRNA (accession no. XM_001538005.1) with an identity of 93%. Through analysis of all data from the lung tissue sample, a read of 1358 bp was found to have an identity of 90.88% with *Histoplasma* NAm1 hypothetical protein partial mRNA (accession no. XM_001541862.1) ([Figure 4](#f0025){ref-type="fig"} ) \[[@bb0080]\].Figure 4Aligned result of a typical nanopore sequencing read obtained from the lung tissue of patient No. 1.Fig. 4

The serum sample from patient No. 2 and mixed tissue samples from patients No. 1 and 2 were also tested sequentially using the Ion Torrent PGM system, while a bronchoalveolar lavage fluid (BALF) sample, plasma and CSF from patient No. 3 (severe case were tested by IVDC using the Illumina MiniSeq apparatus). The time for Ion Torrent sequencing of the deceased patients was around 40 h; a total of 9,810,285 reads were obtained from the serum, and a total of 11,284,703 reads were obtained from the mixed tissue samples. The time for Illumina sequencing of samples from the severe case was around 20 h; a total of 5,829,534 reads, 8,739,522 reads, and 6,100,936 reads were obtained from the BALF, plasma and CSF sample respectively. The data generated by the Ion Torrent platform were aligned with the genomic database of *Histoplasma*, and specific reads were found in the serum and mixed brain and lung tissue from the deceased patients and in the plasma from the severe case ([Figure 5](#f0025){ref-type="fig"} ) \[[@bb0080]\].Figure 5Aligned result of typical PGM sequencing read obtained from plasma from patient No. 3.Fig. 5

3.4. Real-time PCR {#s0065}
------------------

Regardless of the sample type (whole blood, serum, CSF, or nasopharyngeal swabs) or severity of disease of these patients, real-time PCR results for all the samples were virus-negative (data not shown).

4. Discussion {#s0070}
=============

Generally, *Histoplasma* can be diagnosed by microscopic identification of H. *capsulatum* from the microbial culture of tissues or body fluids or from biopsy tissue samples of patients *H*. *Capsulatum* can be found in pathological sections by PAS staining, Gomori hexamine silver staining, and Wright-Giemsa staining, but not by HE staining. The fungus needs to be distinguished from other pathogens such as *Penicillium marneffei* and *Leishmania*, which to a great degree depends on the experience of the expert in pathobiology. The positive rate of clinical specimen culture is related to the symptom severity of the disease and the quality of the sample. Detection of *Histoplasma* antigens targeting the *Histoplasma* polysaccharide antigen in urine and serum samples can be also used for the diagnosis of this disease, and usually, urinary detection is more sensitive than serum detection. Unfortunately, commercial kits to detect *Histoplasma* antigens based on enzyme immunoassay are still not available in China. PCR, nested PCR and real-time PCR using *Histoplasma* specific primers were reported to distinguish cultured *Histoplasma* from other pathogenic fungi \[[@bb0070]\]. There are few reports on the detection of capsular *Histoplasma* by high-throughput sequencing.

Human activities such as excavation, demolition, and cave exploration in areas where *Histoplasma* is endemic result in the risk of infection. Therefore, construction workers, demolition workers, farmers, gardeners, air-conditioning maintenance personnel, historic building reformers, geologists, cave explorers, and so on are at high risk of infection. In the event described here, all patients were exposed to bat excretion during work in four abandoned mining tunnels in Matthews Ridge, Guyana. The presenting clinical symptoms of the patients and the mortality rate (10%--20%) were in accordance with those expected for *Histoplasma* infection \[[@bb0085],[@bb0090]\].

Different testing methods were implemented in response to this unexplained disease cluster. A TGS platform (nanopore) was the first to provide evidence that *Histoplasma* caused this outbreak. In comparison with NGS, the advantages of nanopore sequencing are its ability to record long sequences. In addition, the system is simple to use, fast, high portability, thus, allows it to be used on real-time analysis of sequencing. MinION has been increasingly applied in the fields of virus detection, viral whole-genome sequencing, and viral evolution \[[@bb0095], [@bb0100], [@bb0105], [@bb0110]\]. NGS was also successfully applied in response to the event described in this paper. Though NGS using MiniSeq and MGI2000 systems worked slower (24 h) than nanopore sequencing (13 h), it fitted well with different sample types and was more sensitive. The sensitivity is closely related to the read numbers by NGS. We obtained read numbers of 228,453,930, 189,759,510 and 236,103,930 from the three samples (BALF, CSF and plasma) obtained from the severe case by, and all of them tested positive for *H. capsulatum*. In this case, NGS also identified specific fragments of *Histoplasma* in all tested samples (lung, brain and blood serum) from the deceased patients, which consolidated the identification of *Histoplasma* as the causative pathogen, indicating higher detection sensitivity by NGS than nanopore sequencing.

Real-time PCR assays did not reveal any infection with viruses related to bat feces transmission in any samples we tested, indicating viral agents were likely, not involved in this epidemic. Pathological detection results showed the presence of spore-like structures in the lung tissue from deceased patient No. 1, indicating a fungal infection in this patient.

Additionally, however, NGS and TGS technology showed many reads from *Acinetobacter baumannii* and herpes simplex virus 1 (HSV1) in the bronchoscopy lavage samples from the severe case (patient No. 3). These results indicated that the severe case was originally infected with capsular *Histoplasma*, and then infected with *A. baumannii*, and latent HSV1. These conclusions provide important clues for further study of the pathogenesis of *Histoplasma*.

The presence of *Histoplasma* nucleic acids in tissue, serum, and plasma from postmortem and severely ill patients were cross-validated by three independent laboratories (China CDC, Beijing University of Chemical Technology and BGI) and *Histoplasma* antigen was detected in five patients by the CARPHA Laboratory, Guyana, using enzyme immunoassay on April 12th, 2019. We conclude that *Histoplasma* was the causative pathogen of this disease cluster based on epidemiologic, clinical, pathological and nucleic acid evidence.
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